Global Search | Novartis

Sort by

Relevance

Newest first

Oldest first

Hide Filters

Showing 2751 results

Case study*: Breezhaler® Carbon Footprint
Statement / Apr 19, 2022

Novartis provides more than USD 25 million in medical aid to patients in Ukraine and bordering countries
Press release / Sep 24, 2015

Novartis appoints James E. Bradner, MD as President of the Novartis Institutes for BioMedical Research as Mark Fishman retires

New leader to continue to drive long-term innovation in Novartis research in wide range of therapeutic areas Basel, September 24, 2015 - Novartis announced today that Dr. James (Jay) E.…
Dry Eye disease
Statement / Mar 22, 2022

Novartis condemns the war in Ukraine - update March 22
Statement / Mar 04, 2022

Novartis condemns the war in Ukraine and commits to supporting humanitarian efforts
Abstract summaries for EULAR
Complement-mediated kidney diseases and their impact
Statement / Mar 08, 2022

Novartis expands humanitarian efforts in Ukraine through donation of essential medicines
Press release / Feb 16, 2021

Novartis Entresto® granted expanded indication in chronic heart failure by FDA

Entresto is the first and only therapy approved in the US to treat patients diagnosed with guideline-defined heart failure to include both those with heart failure with reduced ejection fraction (…